Luoting Yu Selected Research

Luoting Yu Research Topics

Disease

35	Neoplasms (Cancer) 06/2022 - 06/2012
16	Neoplasm Metastasis (Metastasis) 06/2022 - 01/2014
6	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2014
5	Melanoma (Melanoma, Malignant) 06/2022 - 02/2016
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2020
2	Carcinogenesis 08/2021 - 01/2019
2	Inflammation (Inflammations) 07/2021 - 02/2017
2	Lung Neoplasms (Lung Cancer) 01/2020 - 08/2013
2	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 01/2014
2	Triple Negative Breast Neoplasms 01/2019 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2016 - 12/2014
2	Carcinoma (Carcinomatosis) 08/2013 - 05/2012
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 02/2022
1	Stomach Neoplasms (Stomach Cancer) 08/2021
1	Fibrosis (Cirrhosis) 07/2021
1	Lymphoma (Lymphomas) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Autoimmune Hepatitis 10/2019
1	Hepatitis 10/2019
1	Hepatitis C 09/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Colonic Neoplasms (Colon Cancer) 09/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2017
1	Hematologic Neoplasms (Hematological Malignancy) 02/2017
1	Nervous System Diseases (Neurological Disorders) 02/2017
1	Obesity 02/2017
1	Infections 01/2016
1	Bacterial Infections (Bacterial Infection) 01/2016
1	Lymphatic Metastasis 07/2015

Drug/Important Bio-Agent (IBA)

15	Pharmaceutical PreparationsIBA 02/2022 - 01/2014
6	Biological ProductsIBA 01/2022 - 02/2017
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2011
4	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2018
3	nifuroxazide (Akabar)IBA 06/2022 - 02/2016
2	Histone-Lysine N-MethyltransferaseIBA 03/2022 - 08/2019
2	Therapeutic UsesIBA 02/2022 - 09/2017
2	Bleomycin (Blenoxane)FDA LinkGeneric 02/2022 - 07/2021
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2021 - 02/2014
2	Trifluoperazine (Stelazine)FDA LinkGeneric 01/2021 - 01/2018
2	Caspase 3 (Caspase-3)IBA 01/2020 - 01/2018
2	Enhancer of Zeste Homolog 2 ProteinIBA 01/2020 - 02/2016
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 02/2016
2	Phosphotransferases (Kinase)IBA 01/2020 - 10/2018
2	Caspase 9IBA 01/2020 - 12/2014
2	cryptotanshinoneIBA 12/2019 - 08/2016
2	ZLD1039IBA 02/2016 - 01/2016
2	N- methyl- 4- (4- (3- (trifluoromethyl)benzamido)phenoxy)picolinamide4- methylbenzenesulfonateIBA 07/2015 - 08/2013
1	Hydroxyproline (4 Hydroxyproline)IBA 02/2022
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2022
1	snake venom protein C activatorIBA 11/2021
1	indium-bleomycinIBA 07/2021
1	IndazolesIBA 04/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	CyclinsIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Androgen Antagonists (Antiandrogens)IBA 01/2020
1	enzalutamideIBA 01/2020
1	Penfluridol (Semap)IBA 01/2020
1	Tubulin ModulatorsIBA 12/2019
1	pectolinarigeninIBA 11/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2019
1	Alanine Transaminase (SGPT)IBA 10/2019
1	Concanavalin AIBA 10/2019
1	TriazolesIBA 10/2019
1	pyridineIBA 10/2019
1	Viral RNAIBA 09/2019
1	Fluphenazine (Prolixin)FDA LinkGeneric 01/2019
1	PDZ-binding kinaseIBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2017
1	Liposomes (Liposome)IBA 09/2017
1	BenzenesulfonamidesIBA 02/2017
1	YLT256IBA 07/2016
1	EnzymesIBA 02/2016
1	MethyltransferasesIBA 02/2016
1	VimentinIBA 02/2016
1	AntidiarrhealsIBA 02/2016
1	2- (2- methyl- 1,4- dioxa- 8- azaspiro(4.5)dec- 8- yl)- 8- nitro- 6- (trifluoromethyl)- 4H- 1,3- benzothiazin- 4- oneIBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 07/2015
1	Vascular Endothelial Growth Factor DIBA 07/2015
1	benzothiazoleIBA 12/2014
1	YLT192IBA 08/2014
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2014
1	AlginatesIBA 08/2014
1	PD 173074IBA 02/2014
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 02/2014
1	N- (5- bromopyridin- 2- yl)- 2- ((6- (2- chloroacetamido)benzo(d)thiazol- 2- yl)thio)acetamideIBA 01/2014

Therapy/Procedure

14	Therapeutics 11/2021 - 06/2012
4	Oral Administration 01/2020 - 08/2014
3	Drug Therapy (Chemotherapy) 10/2018 - 08/2013
1	Segmental Mastectomy (Lumpectomy) 06/2022
1	Intraperitoneal Injections 02/2022
1	Immunotherapy 01/2021
1	Castration 01/2020